| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3298d18dc21dd4b1e0854d2e495f7bcd |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-16734
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-58 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-25 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-522
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-25 |
| filingDate |
2010-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e55ad3af725c2b548789b65ebb9945b |
| publicationDate |
2011-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2011064254-A1 |
| titleOfInvention |
Use of a vaccine against the vzv/hsv3 virus for treating hsv1 and/or hsv2 herpes virus infections |
| abstract |
Herpes is a contagious viral disease which is responsible for reoccurring rashes, and which is extremely widespread throughout the world. To date, no vaccine against herpes exists which enables the entire population to be treated. According to the invention, for the first time a vaccinal composition directed against the HSV3 virus, the varicella-zoster virus, enables HSV1 and/or HSV2 herpes virus infections to be treated. |
| priorityDate |
2009-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |